0.2525SEK-0.59%Mkt Cap: 299.84M SEKP/E: —Last update: 2026-06-01
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and adva…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap299.84M SEK
Enterprise Value275.83M SEK
Revenue (TTM)8.06M SEK
Gross Profit6.24M SEK
Net Income (TTM)-48.09M SEK
Revenue/Share0.0070 SEK
Last Price0.2525 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-6.63
EV/Revenue34.24
P/S37.44
P/B8.19
EPS (TTM)-0.04
EPS (Forward)0.00
52W Range
0.224511% of range0.4710
52W High0.4710 SEK
52W Low0.2245 SEK
Profitability
Gross Margin84.74%
Oper. Margin-348.72%
EBITDA Margin0.00%
Profit Margin-653.32%
ROE-125.99%
ROA-99.51%
Growth
Revenue Growth40.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-37.28M SEK
CapEx (TTM)757.00K SEK
FCF Margin-287.31%
FCF Yield-7.72%
Net Debt-25.79M SEK
Net Debt/EBITDA0.62
Balance Sheet
Debt/Equity—
Current Ratio5.72
Quick Ratio4.76
Book Value/Sh0.0310 SEK
Cash/Share0.0220 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Target (Mean)0.4000 SEK
Target Range0.4000 SEK – 0.4000 SEK
# Analysts1
Ownership
Shares Out.1.19B
Float1.05B
Insiders15.26%
Institutions1.28%
Technical
SMA 500.2747 (-8.1%)
SMA 2000.2835 (-10.9%)
Beta-0.26
S&P 52W Chg27.70%
Avg Vol (30d)1.50M
Avg Vol (10d)1.68M
Technical Indicators
RSI (14)39.4
MACD-0.0056
MACD Signal-0.0052
MACD Hist.-0.0004
BB Upper0.2722 SEK
BB Middle0.2617 SEK
BB Lower0.2512 SEK
BB Width8.02%
ATR (14)0.0130 SEK
Vol Ratio (20d)0.64x